Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer's Disease Treated With Cholinesterase Inhibitors. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.